ScieGen Pharmaceuticals

ScieGen Pharmaceuticals
Author :

iyrin-health

Uploaded Date : October 1, 2024 Last Updated Date : January 31, 2025

About ScieGen Pharmaceuticals

ScieGen Pharmaceuticals, Inc., headquartered in Hauppauge, New York, is a leader in the generic pharmaceutical industry. Their commitment to excellence is reflected in their approach to developing, manufacturing, and marketing high-quality generic pharmaceutical products.

At Sciegen Pharmaceuticals, they are dedicated to enhancing patient access to affordable healthcare by providing cost-effective medications without compromising on quality.

ScieGen Pharmaceuticals India R&D Facility

ScieGen Pharma has a research and development facility in Hyderabad, India. They have built a facility that covers more than 13,000 square feet and is designed to adhere to both local and US FDA requirements. This helps in ensuring the highest standards of quality and compliance.

The company overview, along with the Corporate Identification Number (CIN) for Sciegen Pharmaceuticals, located in India, is provided below.

Company Overview

  • Corporate Identification Number (CIN): U24240TG2013PTC085471
  • Incorporation Date: 28-01-2013
  • Registered Office: Plot No.70 & 71, Ground Floor, ALEAP Industrial Area, Pragathi Nagar, Hyderabad – 500 090. Telangana. India.
  • Registered Office For The USA- 89 Arkay Drive, Hauppauge, New York 11788.
  • Email: info@sciegenpharm.com.

Board of Directors

  • Dr. Pailla Malla Reddy- Chief Executive Officer.
  • Siva Reddy Palempalli- Chief Operating Officer.
  • Saketh Reddy- Chief Commercial Officer.
  • Dr. Raghuram Pannala- Senior VP CQC , RA & PV.
  • Krishna Chilakamarthy- Associate Vice President.
  • Brett Barczak- Senior Vice President, Sales & Marketing.

Manufacturing Practices And Quality Assurance

ScieGen Pharmaceuticals is inclined towards developing, manufacturing, packaging, and delivering the highest quality pharmaceutical products at an affordable cost.

They follow all the regulatory guidelines set by the US FDA to ensure the quality of the product. ScieGen Pharmaceuticals is also DEA certified license holder for their labs and manufacturing units.

Why Choose ScieGen Pharmaceuticals?

Some of the key reasons to choose Soma medication by ScieGen Pharmaceuticals include-

  • They offer quality medication at an affordable price.
  • All the medications are manufactured while following all the regulatory protocols to maintain effectiveness and safety.
  • They are a trusted pharmaceutical company recommended by doctors and pharmacists.
  • They are registered to distribute medication in all 50 states in the USA, thus showcasing their quality of medication.

ScieGen Pharmaceuticals’s Medications Available At IyrinHealth

We primarily retail Carisoprodol or Soma pill brand drugs by ScieGen Pharmaceuticals. We offer Soma Dol tablets in the dosage strength of 350mg, 500mg, and 750mg.

This medication works within 30 minutes of intake and helps in treating short-term acute pain.

References

  1. Sciegen Pharmaceuticals India Private Limited, Cleartax.

Disclaimer

Legal & Medical Disclaimer: This website is operated as an India-based pharmaceutical supply platform. Products are manufactured and dispatched from India. Content is for educational purposes only and is not medical advice. We do not diagnose, prescribe, or recommend treatment. Availability and legal status of medicines vary by jurisdiction. By ordering, the buyer initiates import and agrees to comply with local laws, prescription requirements, and import regulations.